Sign in

CIK 0001768224 · Accelerated filer<br>Smaller reporting company

Arcturus Therapeutics Holdings Inc.

Sign in to watch
Ticker
ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
8589002660
Business address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
  1. 8-K Event Results of operations
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 8-K Event Regulation FD disclosure · Other events
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Regulation FD disclosure
  6. 4/A Open-market buy Chief Financial Officer bought 1,238 shares at $16.56 ($20,499)
  7. 4 Open-market buy Chief Financial Officer bought 1,238 shares at $16.56 ($20,499)
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 8-K Event Regulation FD disclosure
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 8-K Event Shareholder vote results

Page 3 of 21 · 416 filings